An FDA panel spread misinformation about SSRI use in pregnancy, alarming doctors

A panel organized by the FDA cast doubts on the safety of antidepressants during pregnancy — drawing ire from doctors who say SSRIs are a crucial treatment option for women with perinatal depression.